<SEC-DOCUMENT>0001641489-23-000051.txt : 20230811
<SEC-HEADER>0001641489-23-000051.hdr.sgml : 20230811
<ACCEPTANCE-DATETIME>20230811163643
ACCESSION NUMBER:		0001641489-23-000051
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230811
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230811
DATE AS OF CHANGE:		20230811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			vTv Therapeutics Inc.
		CENTRAL INDEX KEY:			0001641489
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473916571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37524
		FILM NUMBER:		231164684

	BUSINESS ADDRESS:	
		STREET 1:		3980 PREMIER DR
		STREET 2:		SUITE 310
		CITY:			HIGH POINT
		STATE:			NC
		ZIP:			27265
		BUSINESS PHONE:		336-841-0300

	MAIL ADDRESS:	
		STREET 1:		3980 PREMIER DR
		STREET 2:		SUITE 310
		CITY:			HIGH POINT
		STATE:			NC
		ZIP:			27265

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VTV Therapeutics Inc.
		DATE OF NAME CHANGE:	20150506
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>vtvt-20230811.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:399e4592-567a-4e81-aea2-167c555265d1,g:79d511f5-4fcd-4788-bf62-ef4138a9e3b8,d:088f330a0a144845a1894ae48c4eafc3--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>vtvt-20230811</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001641489</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" id="f-23">NASDAQ</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="vtvt-20230811.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001641489</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-11</xbrli:startDate><xbrli:endDate>2023-08-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i088f330a0a144845a1894ae48c4eafc3_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:0.05pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(D) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (date of earliest event reported):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 11, 2023</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">vTv Therapeutics Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37524</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">47-3916571</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission File No.)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(IRS Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3980 Premier Drive, Suite 310</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">High Point</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">NC</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">27265</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">336</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">841-0300</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOT APPLICABLE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General Instruction A.2. below):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#168;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:38.050%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.051%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Class&#160;A common stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">VTVT</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" id="f-19">NASDAQ</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#168;</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:0.05pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i088f330a0a144845a1894ae48c4eafc3_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2.02 Results of Operations and Financial Condition</span></div><div style="margin-top:10pt;text-align:justify;text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2023, vTv Therapeutics Inc. issued a press release to announce its financial results for the fiscal period ended June 30, 2023.&#160;&#160;A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:58.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information in this report (including Exhibit 99.1) shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18, of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div id="i088f330a0a144845a1894ae48c4eafc3_10"></div><div style="-sec-extract:summary;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;9.01 Financial Statements and Exhibits</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Exhibits</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="vtvt-20230630xexx991pressr.htm">Press Release dated August 11, 2023, announcing financial results for the fiscal quarter ended June 30, 2023</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i088f330a0a144845a1894ae48c4eafc3_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.415%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.811%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VTV THERAPEUTICS INC.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Paul J. Sekhri</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paul J. Sekhri</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">President and Chief Executive Officer</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: August 11, 2023</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>vtvt-20230630xexx991pressr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i9347d839d5b64163a8f4823c04443978_1"></div><div style="min-height:54pt;width:100%"><div style="padding-left:49.5pt;text-indent:-36pt"><font><br></font></div></div><div style="margin-bottom:50pt;margin-top:0.05pt;text-align:right"><img alt="vtvv_outlinexcolorxnotaglia.jpg" src="vtvv_outlinexcolorxnotaglia.jpg" style="height:150px;margin-bottom:5pt;vertical-align:text-bottom;width:190px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">HIGH POINT, N.C. - August&#160;11, 2023 &#8211; vTv Therapeutics Inc. (Nasdaq&#58; VTVT), a clinical stage biopharmaceutical company focused on the development of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">cadisegliatin (TTP399)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as an adjunctive therapy to insulin for the treatment of type 1 diabetes (&#34;T1D&#34;), today reported financial results for the second quarter ended June&#160;30, 2023 and provided an update on recen</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">t corporate developments.</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;In the first half of 2023, we made further progress in the development of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">cadisegliatin</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as an adjunctive therapy to insulin for the treatment of type 1 diabetes,&#34; said Paul Sekhri, Chief Executive Officer of vTv. &#34;The Breakthrough Therapy Designation granted to </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">cadisegliatin</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> has enabled us to actively engage with the FDA to align on the design and conduct of the planned Phase 3 study. Further, our partners at Cantex Pharmaceuticals have made exciting progress on the development of </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">azeliragon</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, a small-molecule RAGE inhibitor discovered by vTv, as a potential treatment for a variety of oncology and related indications. Overall, we believe we are well positioned heading into the second half of the year and look forward to providing updates, as appropriate, on our partnered programs as well as </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">cadisegliatin</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as we advance toward the initiation of Phase 3 study activities, which we continue to expect by year-end. The initial phase 3 study will test the FDA&#8217;s recommended primary endpoint, which is the reduction in the number of hypoglycemic events between placebo and </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">cadisegliatin</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> treated groups.&#34;</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Company Highlights </font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On July 17, 2023, the Company received notice from Nasdaq that it had approved the Company&#8217;s request to extend the period for the Company to regain compliance with the Minimum Bid Requirement until December 18, 2023. </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Second Quarter 2023 Financial Results</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;padding-left:49.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:32.5pt">Cash Position</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#58;&#160;The Company&#8217;s cash position as of June&#160;30, 2023 was $12.6 million compared to $12.1 million as of December&#160;31, 2022. </font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;padding-left:13.5pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:49.5pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;padding-left:31.8pt">Research &#38; Development (R&#38;D) Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#58;&#160;R&#38;D expenses were $4.7 million and $2.2 million in each of the three months ended June&#160;30, 2023 and 2022, respectively. The increase of $2.5 million is primarily attributable to higher spending on </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">cadisegliatin,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> due to increases in drug product related costs, and an increase in indirect costs related to the development of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">cadisegliatin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">General &#38; Administrative (G&#38;A) Expenses&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;G&#38;A expenses were $3.3 million and $1.8 million for each of the three months ended June&#160;30, 2023 and 2022, respectively. The increase of $1.5 million was primarily due to higher payroll cost and higher other G&#38;A costs.</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">Other Income (Expense)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; Other income for the three months ended June&#160;30, 2023 was $0.6 million and was driven by an unrealized gain related to our investment in Reneo, as well as gains related to the change in the fair value of the outstanding warrants to purchase shares of our stock issued to related parties. Other expense for the three months ended June&#160;30, 2022 was $0.1 million and was driven by an unrealized loss related to the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="padding-left:49.5pt;text-indent:-36pt"><font><br></font></div></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment in Reneo as well as the gains related to the change in the fair value of the outstanding warrants to purchase shares of our own stock issued to a related party.</font></div><div style="margin-top:12pt;padding-left:49.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.5pt">Net Loss</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;&#160;Net loss attributable to vTv shareholders for the three months ended June&#160;30, 2023 was $5.6 million or $0.07 per basic share. Net loss attributable to vTv shareholders for the comparable period a year ago was $3.2 million or $0.04 per basic share.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9347d839d5b64163a8f4823c04443978_4"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="padding-left:49.5pt;text-indent:-36pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">vTv Therapeutics Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(in thousands)</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.958%"><tr><td style="width:1.0%"></td><td style="width:71.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.982%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.003%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">June 30,<br>2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,<br>2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,599&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,126&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G42 Promissory Note receivable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,243&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,324&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,537&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current deposits</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,938&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,094&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">207&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">299&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">349&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term investments</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,027&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,588&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,426&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,238&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities, Redeemable Noncontrolling Interest and Stockholders&#8217; Deficit</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,108&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,313&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of operating lease liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">161&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of contract liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of notes payable</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">224&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9,286&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,708&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,669&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,669&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">256&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">338&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrant liability, related party</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">619&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">684&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28,830&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27,399&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,879&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16,579&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; deficit&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class A Common Stock</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">815&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class B Common Stock</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">254,479&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253,737&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(280,809)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(265,524)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders&#8217; deficit attributable to vTv Therapeutics Inc.</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(25,283)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,740)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities, redeemable noncontrolling interest and stockholders&#8217; deficit</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22,426&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,238&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i9347d839d5b64163a8f4823c04443978_7"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="padding-left:49.5pt;text-indent:-36pt"><font><br></font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">vTv Therapeutics Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(in thousands, except per share data)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months Ended<br>June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Six Months Ended<br>June 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Unaudited)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue </font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,009</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development </font></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,691</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,205</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,633</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,338</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative </font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,309</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,831</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,794</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7,179</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses </font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,000</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,036</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,427</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12,517</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating loss</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8,000)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,027)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15,427)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,508)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">253</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">638</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(114)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,191</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,856)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss before income taxes and noncontrolling interest</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,211)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,091)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,985)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13,315)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax provision</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss before noncontrolling interest</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7,211)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,091)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,985)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13,515)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less&#58;  net loss attributable to noncontrolling interest</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,592)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(940)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,867)</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,357)</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to vTv Therapeutics Inc.</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,619)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,151)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,118)</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,158)</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss attributable to vTv Therapeutics Inc. common shareholders</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5,619)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3,151)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,118)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10,158)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share of vTv Therapeutics Inc. Class A common stock, basic and diluted</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.07)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.04)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.12)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.15)</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average number of vTv Therapeutics Inc. Class A common stock, basic and diluted</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,483,600&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70,366,823&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81,483,600&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,664,259&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About vTv Therapeutics</font></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">vTv Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cadisegliatin (TTP399)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a potential adjunctive therapy to insulin for the treatment of type 1 diabetes. vTv&#8217;s development partners are pursuing additional indications in type 2 diabetes, chronic obstructive pulmonary disease, renal disease, primary mitochondrial myopathy, and glioblastoma and other cancers and cancer treatment-related conditions.</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This release contains forward-looking statements, which involve risks and uncertainties. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this release, including statements regarding the timing of our clinical trials, our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Important factors that could cause our results to vary from expectations include those described under the heading &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K and our other filings with the SEC. These forward-looking statements reflect our views with respect to future events as of the date of this release and are based on assumptions and subject to risks and uncertainties. In addition, we may not be able to successfully complete a successful financing, partnering or licensing transactions with respect to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">cadisegliatin</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. We anticipate that subsequent events and developments will cause our views to change. Our forward-looking statements do not reflect the potential impact of any future acquisitions, merger, dispositions, </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="padding-left:49.5pt;text-indent:-36pt"><font><br></font></div></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">joint ventures, or investments we may undertake. We qualify all of our forward-looking statements by these cautionary statements.</font></div><div style="margin-bottom:0.05pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contacts&#58;</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investors&#58;</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lee Roth</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Burns McClellan</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">lroth&#64;burnsmc.com</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font><br></font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Media&#58;</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selina Husain &#47; Robert Flamm, Ph.D.</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Burns McClellan, Inc.</font></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shusain&#64;burnsmc.com &#47; rflamm&#64;burnsmc.com</font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>vtvt-20230811.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:399e4592-567a-4e81-aea2-167c555265d1,g:79d511f5-4fcd-4788-bf62-ef4138a9e3b8-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:vtvt="http://vtvtherapeutics.com/20230811" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://vtvtherapeutics.com/20230811">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtvt-20230811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vtvt-20230811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://vtvtherapeutics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>vtvt-20230811_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:399e4592-567a-4e81-aea2-167c555265d1,g:79d511f5-4fcd-4788-bf62-ef4138a9e3b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_6100a3e9-9d73-4148-af78-4ca4c1d97c3f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b6319ce8-5d16-4dc6-9216-4e47a8711981_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_927723db-f0e4-4f07-adfd-3853e7d6324b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_08ad33d2-9f6f-4503-b3de-9cdb38d3823f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f3f9380b-af10-4282-a66e-5cce35c99240_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_113f332e-7adc-4d7b-9216-480cf1c1879b_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a6d1ffd2-2e72-4844-9bc1-b13a93fff84f_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_90e26e96-f28d-4373-aef7-7c58fc0e8861_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a2949ece-d722-4197-ad6d-d4c8c00c5595_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_e70d5c02-b03d-4581-853c-7f79b9b3b24d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_1eb59561-3020-4f3f-9f4f-a199915a5f49_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_27cebbe2-4d22-4228-9849-627ec3094240_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e85de848-b566-4aba-a40f-790bd77c0957_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3917348c-376c-4088-bf7e-86cc00b38644_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_82173bf0-cf6d-4434-affc-3b7edcb5656f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_acba9bd3-3236-4e92-8f87-1c60cbd3042a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5e513bf2-3686-4612-908e-0b2928bfe236_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_cc836cb0-20d1-4c05-85a6-04ef663d9b34_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_975b6fc6-881e-4a83-99f0-1c87db988557_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4b45ec66-41e6-4e51-8d05-1ba5f7b084e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a97e9a04-d365-460c-8e55-abf23abb8004_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_51f72442-3e13-4620-84ea-3c410cebd4d8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>vtvt-20230811_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:399e4592-567a-4e81-aea2-167c555265d1,g:79d511f5-4fcd-4788-bf62-ef4138a9e3b8-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://vtvtherapeutics.com/role/Cover" xlink:type="simple" xlink:href="vtvt-20230811.xsd#Cover"/>
  <link:presentationLink xlink:role="http://vtvtherapeutics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_2fb6b589-225a-4f11-a980-24828d9adabc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_DocumentType_2fb6b589-225a-4f11-a980-24828d9adabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d1e2553c-3197-4991-a284-3b27c5a24582" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_DocumentPeriodEndDate_d1e2553c-3197-4991-a284-3b27c5a24582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d159544d-66ae-43a3-a55b-6551592029b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityRegistrantName_d159544d-66ae-43a3-a55b-6551592029b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ba296a99-fad2-49ad-9bea-cbc8b902b37e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ba296a99-fad2-49ad-9bea-cbc8b902b37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0003c6da-eac4-4249-ac8f-df77e47edede" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityFileNumber_0003c6da-eac4-4249-ac8f-df77e47edede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_247493fa-b2c4-49a5-afb3-0abe1164b984" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityTaxIdentificationNumber_247493fa-b2c4-49a5-afb3-0abe1164b984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b9f48bcb-a35c-498a-8e4f-f67c5ad4bd14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityAddressAddressLine1_b9f48bcb-a35c-498a-8e4f-f67c5ad4bd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0f01a03e-a8e6-4a5b-981e-09668a702f7b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityAddressCityOrTown_0f01a03e-a8e6-4a5b-981e-09668a702f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_290835f2-8206-4a7d-bd84-cf06df53574c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityAddressStateOrProvince_290835f2-8206-4a7d-bd84-cf06df53574c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ae638b1c-1f50-40af-b8e8-43e174db09ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityAddressPostalZipCode_ae638b1c-1f50-40af-b8e8-43e174db09ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_bb6f1e8b-ddaa-4bc3-a874-7514e16ef1f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_CityAreaCode_bb6f1e8b-ddaa-4bc3-a874-7514e16ef1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_73b93d99-1207-4c49-8df8-d2dc4be3f945" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_LocalPhoneNumber_73b93d99-1207-4c49-8df8-d2dc4be3f945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_578b53d7-f4d4-4b9f-b96e-1c91cac70878" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_WrittenCommunications_578b53d7-f4d4-4b9f-b96e-1c91cac70878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_63c414b0-45ce-4ea8-8740-809d311be14c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_SolicitingMaterial_63c414b0-45ce-4ea8-8740-809d311be14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_cab84f5a-246b-4f91-8b6f-1e83a64e9398" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_PreCommencementTenderOffer_cab84f5a-246b-4f91-8b6f-1e83a64e9398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_fb6b052f-2947-4396-8575-7d3d9a0b33c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_fb6b052f-2947-4396-8575-7d3d9a0b33c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_720e32cc-7d80-4a7f-9568-8a4ff74fe1f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_Security12bTitle_720e32cc-7d80-4a7f-9568-8a4ff74fe1f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3a1933f0-f2f9-437e-bac3-5d269c935c73" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_TradingSymbol_3a1933f0-f2f9-437e-bac3-5d269c935c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2a651cc8-deb8-4964-8460-82140f6244f5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_SecurityExchangeName_2a651cc8-deb8-4964-8460-82140f6244f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9a400292-8c14-43fd-87f2-157a53dd8104" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityEmergingGrowthCompany_9a400292-8c14-43fd-87f2-157a53dd8104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6c5b2f72-7008-46c5-8256-84a8d4fa09ce" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_AmendmentFlag_6c5b2f72-7008-46c5-8256-84a8d4fa09ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_fcbeaa7e-7c54-4e5f-b752-25d795f30b64" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_f8ab7b72-fcf6-46bd-bdf4-e80ee5dd35dd" xlink:to="loc_dei_EntityCentralIndexKey_fcbeaa7e-7c54-4e5f-b752-25d795f30b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>vtvv_outlinexcolorxnotaglia.jpg
<TEXT>
begin 644 vtvv_outlinexcolorxnotaglia.jpg
M_]C_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T      ! !+     $  0$L
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M=RI8*ZW5<-?0U3$DI:RGD;+%(Q>QS'L56N1?2B@Y"K*D
M
M
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MSZ\YA4+(LD4%?4N6E@5=>%/2,Y8($XKPC8U/4"G<]SOG*JEIRV8/D
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M?33N<O8V*5SOTJ J&RL?V+HOH4S?,P@<@
M
M
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M2.1R_-8O:"J9,Q_#YJ^A38F9W@Y0
M
M
M       #%_JAZM]I>E#$&Y#N#<G5E_NC)$Q' [>YC[I=96<%5C'*B10L54\2
M9_NM[$YGJUCL=.HSJ?VPZ9\6;?,YN#JN]W%CTQ?"Z%6NN-RE9P56,542.)JJ
MG/*_W6]B<SU:QP^'O:Q-5^1"*KU3=9>\75?D:UV<75;1AMOG=)B^W%M>YMLH
M&]C7O3@M3/R_.FEU7BJ,1C%Y$C6]2'5ANMU,W]:S,+DMKQ.AF=)CF V][FVZ
MB;V->]."U$VG;+)QXJC$8Q>1!1/D<]>/!.YIB:8R XP
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MH7?+I@^@
M
M                                         #7WUQ=>N$])>//L-I;2
MY;O9?*19L8PUSG.IZ*-Z\K*ZZK&YKF0HNJLC1R/E5-&JUO-(W!WK%ZU<0Z8K
M&^RVQ*;)]WKS2^+CV)N5704C'KRMK;DL;FN9$G%6L14?*J:-5K>9[1Q22I&G
MI<O8A%#W+W-SK>#-+UN#N/D=7E.67^7Q:^YU;M=&IP9#"Q-&111I[K(V(C6I
MP:B(1G=PMP\SW4RV[YSGU_J<CR:]R^)6W&I=KHU/F11,31L<<:>ZQC$1K4X(
M@*%SE<JJJZJIX,\6#\
M      +N;+;Y[H=/F:T6>[59148Y>Z?2.MA;]\HZ^FYD5U+6TSO<FB=Z')JU
M?>8K7HUR70VCWDW%V-RZDS7;7(Y[!>(-&5<3?OE+6T^NKJ:LIW>Y-&[T.35%
M]YJM<B.0?37.8NK5T)5?19UZ;==6UC;:)&Q8;O%:*99LDP&635D\<>B/K;7(
MY=9H%5R<S5^^1+P<BMY9'R4^D?K4P/J>L[;7(V+$]U;73K+?\)D?JV9C-$=5
MVZ1RZRPKJG,U??C7@Y%;RO>*Z.5)$]#N]#/4S5!R
M
M
M          & 77EUO8YTEX,ENL[Z>][SYA22_D-C3T\2*DCU\-UTN#45%;!&
M[5&-UUE>G*WW6R.9A'UI]8-AZ8L-^ M3H+ONUE--)^1V/O3GCIF:\BW&M:BH
MJ0QNU1C>V5Z<J>ZU[F#BDD2-/TR]B$23,,PR?/\ )[YFF:7RKR3*<DJWUM[O
M=:_Q)ZB>3M<Y>"(B(B(UJ(C6M1&M1&HB$8+*LJR+-\BO&6Y;>*F_Y)?ZE]9>
M+Q6/YYIYG]JJO8B(FB-:B(C41&M1$1$!0JJJJJJZJO:IYLZ 'X
M                                          =[C&3Y#A>06?*\3O-7
MCV28_51UMEO=!*Z&HIIXEU;)&]JHJ*GZ*<%X'<X[D5]Q*^6K)L9NU58L@L=2
MRKM-WHI'13T\T:ZM>Q[=%1?M]B\ ?J*J+JBZ*G>2M.@+K]Q_JEQ^'!\XFI,?
MWVQ^DYKE;6\L-/?J>%OOW"WLX(CT1-9H4^9\]GWO5&26^B/K<L?4A8XL.S&6
MFL>\]CIN:X6]ND4%Z@B3WJZA;V(]$XS0I\WYS?<^8*V*5'IHO!R?HFRLV" Y
M@
M
M                          #&[JIZEL-Z5]I+SN3E*LKKFNM#A>*MDY)[
MO=9&JL-.Q=%5K&HBOE?I[C$5=%=RM=8'J3Z@\3Z;=L+MG^2*VLN"ZT>(XTC^
M2:Z7*1JK% U=%Y6-T5\K]/=8BKQ=RM</A[T8WF7Y$(;&Z^Z>:[U;@9-N9N%=
MGWC*LJJW5-=.O,D43/FQ4U.QRN\.&%B)'&S7W6HB>LB@;F;DY=NYG&0[AYS<
MW77),DJ75%9,NJ1Q-^;%! Q5=R11,1&1MUX-1$!U[G*Y5<O:I;L\(#\
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M.<S55Y51S%5>7F<*^.1)&Z]BIVH9JF7(.0
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MKM%]:(#\^(9Z''%_MJ^EC_Z!W5_\*L?_ /.''_M=.F[_ .B=RO\ PVS_ /\
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M[ 'Z
M                          =9>KS:<<L]UR"_7""T62QTDU?>+K5/2."F
MI:9BRS32O=P:UC&JY57N.ON]VMEAM5ROEZKH;79[/2S5MUN52](X:>G@8LDL
MLCUX-:QK5557N [.)#CZX^K"\]6&\EPR2*:>EVXQ99K5MC8).9J14"/]^LEC
M7@D]8YJ22<-4:C(]52-%(I76-U,W;J9W7KK_ !RS4V!8VLMMV[LC^9J1T2/]
MZKEC7@D]4K4>_AJB<D>JHQ%!U\LG.[]*GS4,,C$P'&
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M(QJ@Y6N:[YJHI=LN@#Z
M                                 -&7G"]5DF.8];NE_"[DL5XRV"&[
M[I5,#E1\%J1_-1VY7M[%J9&>+(W5%\-K$75DJZZ;O-3ZEGV"QT'3IB5P6.Z9
M/#%=-QZB%RHZ&VH_FI*%7)V+4/9XDB=OAM:BZLE744U0_1.1.U?G>PCH&A@%
M(
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M/^*6.>..:&1LT,S4?%*Q4<US7)JCFJG!45.Q0<QR'V
M                                                 6_W5W)QO9_;
MC--S\NJ/A\>PFU5%TN&BHCY?";][@BUX+)-(K8V)WN<B'B-RL_L&U> Y;N)E
M$_@6+$+9/<:[141\GA-^]PQZ\%?*]6QL3O<Y$!^.5&HJKV(0A-UMRLEWBW(S
M3<_+ZE:G(LVNL]SN"\RN9$DBZ14\7-Q2."-&Q1IW,:U.XA[;E[@Y!NKGV6[B
MY34+47W+[E-<:[BJMC21=(X(]>*1PQHV-B=S6H@.M<Y7.5R]JEOCPX/P
M
MN[L+NW>-B=X]O-VK)SOJL)O,%;54D:HU:JB=K%74FJ\$2HIGR1*O=S:ET=E-
MS[KLQNM@FYUGYWU.(76&KJ:5BHBU-&[6.LIM5X(D].]\:KW<VH/ICE:Y')W$
MX?'K]:LJL%CR>PUC+A8\CM]-=+-7Q_,GI*R)L\$K?4]CT5"8E8KU;,DLEGR*
MRU3:ZSW^AI[E::UGS9J:JC;-#(WU.8Y%0'9)QXIV*=P=J
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MC8[36.DI(T;# W@FJ,8FJ\7:KJH*1SW/75RZEH2UH/D
M                       S4Z9NO;J!Z89J*V8SD:Y9M["_^^=ML@<^IMR,
M5=7?!OU\6C=Q54\%R,YEYGQO[#+GIZZU]\>G6:DM^/7Y<FP6)_\ ?&W]\<^H
MH48J^]\(_7Q:5W:J>$Y&<RZO8_L!R,E>SOU3T*24NE/KOV3ZK:"*AQVX+B&Y
M$$*RW7;.\2L2M1&I[\E%*G*RLB337FC1'-3C)&S5"0+TT]:&T/4M11T=AKEQ
M;/H8EDN6WMUE8E8B-3WY*.1.5M7$GTF(CD3B]C-4!6,D:_LX+WM,UC+H'(
M
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MLM#7T$TE-744[%CEAFB<K)(Y&.1%:YKD5%1>**"D[.!2%*
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MB%QJDGOFTMRDL;D<[FD=;:C6JM\CO0UJ/D@;ZH@5T#N9FG>W@;238^#F
M            /"[D;EX+M#AMYS_<?):/%,3L,2RW"[5C]$U^XBB8FKY99%]U
MD;$5[W>ZU%4\;G^X.&;6XI=LWS[(*7&<8LL2R5USJW:)K]S%$Q-7R2/7W61L
M17.7@U%4'XJHU-571$[R+IUK^9+N+U*5-UP3 9*S;S9%7OA=9HG^'<K[&G#Q
M+K-&JZ1.3BE,Q>3C]\654:K8Y'5WU_YYU U%RPS"9*K!=GU<Z)UIC?R7"\QI
MPY[E+&JZ1N3BE.Q>3C[ZR*C5:**297\$X-^V:R#7@#A
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M
M#\54:BN<J-:U-55>"(B'XJHU%551$1-55>Q$ (376#O-)OYU(;K;E,JOBK-<
MKS+08FYKM6)9[:B4= K$[&^)#$V5R)PYWN7CKJ1"NJC=F3>S?W<O<!E3\3::
M^[246,.1VK$M5OTI*)6IV)XD439'(GW3G+QUU!UTCN9[E[N[V&-)CZ#X
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M>/!$[$,/S%<'&
M     2(/+*\PZJR>:R=-^^U]\>_\C*+:O/:Z15DK^5-([37RN[9T1-()7+K)
M^MN59.3Q-[7EY===1D4MGV"WGO/C7OE92;:YK6/59*WE31ELK97=LR(FD,CE
MUD_6W:R<O.*N&77W'+Q^Y7TF]PW/ J0
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M%LM\%%N>&Y=3,BJ>&K:.Y4T\,\::JB^_*R!>&OS>SO0<%0FK$7T*1@2.H"B
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M/F'@.(
MY(9I:>6*>"5\$\#VR0S1N5KV/:NK7-<FBHJ*FJ*A]Q2RP2QS0R.AFA<CXI6*
MK7-<U=4<U4XHJ+V* 2P?+5ZTV]2VW3\#SNY-DWJVWI(F7F65Z>)?+4U6Q0W5
MJ+Q=(URI'4Z:Z/5K^'BHULF;R_.KAO4'@;\+S2X-?NY@%+&V[2R.3Q+Q;6JV
M.*Y-1>*R-54CJ-.QZM?P\5&M%=#)SIHOSD[?6;-S8>#F
M                                        -&OG<[B/H-OMEMJZ:?1<
MFOM?DUTB:NCDCL].VDIT?Z6O=<)%1/2S7N0TX><!G;J+!]I-MH)M%R&]5N0W
M&)JZ*C+5 VF@1WI:]U<]43TLU[D!35*^ZU/2NOV".::%@4@
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MV.J8I')JU;K=624M(W1>"\L*5$B+W.:U>W10<].W5ZN^C_5)2!([!6@
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M-71T5(NCI$XHLW!418DU%)/)JO(B\$^<:133\"F
M                                     +L;';Q99L'NGA^Z^%S\EZQ.
MM;.ZC<Y6PUM*]%CJJ.?3^USQ.<QW>FO,GO(BES-G=U<GV3W)Q7<S$IN2[XQ6
M-F=2N<K8JNF>BLJ*2;3[B:)SF.]&NJ<40'TURL<CD[B:_M+NABF]&V^'[HX3
M6I6XUF=NCKZ!RJGB0N75DU-,B*J-E@E:Z*1.Y[50EX;8[C8SNW@&*[C8A5I6
M8_EE"RMHG*J<\3EU;-!*B:HDD,C71O3N<U4!V**CD14[%+BGO ?H
M                                             !%>\XK-5R3JS@QF
M.H1]/MYAUIM<M,W72.IK73W-[G:_=.BJXNSN1OK(VOFKY>M_ZG(<>CG1\&"X
MI;+=)3MUT945;IKB]SM?NG1U,79W(@**H75^GH0U2&M$'
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M7*^:KJYGNDEEED<KGO>]RJKG.55555=54'7E.<
M                                       !O1\FKJ5?9LHR3IFRBXK]
M5Y4V;(-M$F=PBN5-'S7&BCUU7[_ SQVIP1%BD7YSS<KY3_4$^U9'?^GG(Z]?
MJ[)6RWS;Y)7<([A SFKZ1FO'[_"WQFIP1%B?WO!4T[^*L7OXM)%9OC!5@
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MYXQ?KWC5ZIEH[QCU?4VR[4CNV*II)70S,7^M>Q4!UJIHJHO:G:=*=0#\
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MCN#?51+MF5XK+O6QH[F;$ZJE=(D3%5$]V-%1C>'8B ZURJY5<O:JGA#Q@/P
M             D;>2!??B-MM]L9YD7ZHR6U7/DU;JGUC1RPZJGSN/P7?P]'>
M;[?)ZO/C[?[SX]S(OU7D-LN/)JW5/CZ22+54[>/P??P]'>"KIOFN3UF\8W%@
MJ0       "(]YGW42_?3J4OECL]P?4X)L_XN*XY$UWWF6MAD_P"U:QJ<459*
MAOA(Y%T='%&I%^\Q7?=V\O4#>+-:JYU1A>UGB8W88FK]ZDK(G_\ :54U.*:R
M3M\-')P<R-B@H9W\S].YO UR&! .$
M                               ]=@.;W_;7-\2W!Q6J^#R/"[O1WFS3
MKJK4J*.9LS&R-14YF.5O*]O8YJJB\%/483F%[V_S#&,YQNI^$OV)72ENUIF7
M56I/22ME8UZ(J<S'*WE<WL<U51>"@_456JBIVHNI..VIW&L6[NVV#[G8R_6R
M9S9J2\442N1[X?B8T<^GD5O#Q(7\T;T[G-5"8SMKGMFW1V_P[<3'G:V?,K32
MW6CC5R.=#\1&CGP2*G#GB?K&_P!#FJ#LFJCD14[%XEP#VX/T
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M<I?*BZ,>JFOA6>#8G+(V([EY:BB6F?KHB_,G5CM./;H#[\*3Z"E;_0#ZR?\
MT]Y5^PP_MI5_T).J_P#T&9+^Q1?M@'A2?04?T ^LG_T]Y5^PP_MH_H2=5_\
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MRR4+>6BL]LIHJ2EB3T,AA:UC?D0%2B(G!$T3T'>G<@
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M '"E6;'-J*=<GN+G-U8ZNC<D5MBU[G>.Y)DX<4B<#F@;S/U[F\26D2= 5P
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M%$N35U),Q'Q5%;'*R&@@>BHJ*GBO\;1>"I$K5[0<T#>9^J]C>)+6)/ *X
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M%<4RASG<SUJ;6UL<,DBJJJKIJ5T,KE7M<YP.PB=S,1>]."_(9QF8H.0
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MH_C+]&Q?=?>;I&R3E=HNCO I?#T7N621H*.H=JY&I]SV^TTTFIX%.
M           ;]/(VMCW5O4I>7)(UD,&)T4+N7[V]977:21$=])GAMX)]+CW&
M[3R<;<YU7U W9R2-9##C-)$O+[CUD==)'Z.]+>1O#]-[ 55-]W\A((-X@*H
M   MUN]F\>VFU&Y>XDCV,3!L7N]]9XFG*Y]OHY:AC-%[5<YB-1.]5T/![I9@
MS;[;3<'.Y',8F'8Y=+TWQ-.57T-+).QNB]JN<Q$1.]5T!^.7E:J^A-2"9--+
M42RSSROGGG>Z2::1RN>][EU<YSEU5555U55(8TLLL\LDTTCIIIG*^65ZJYSG
M.757.5>*JJ]J@ZPXSX           -_WD9P4J_TG*G1'5K/R-B158FK(G?7;
MO=DUU]]6\4T^Y3M[MWGDWPTZ_P!(BHT1U6S\E(]58FK(W?7"^Z_77WE;Q3]*
MG;W"JION_D_JF_XW> J@                                       "
M$UUFLI6=6G4>E(D:1+N+D+G^%IR^*ZOE6773[KQ%=S>O4B%]6;:=G4YOZE*D
M:1+GE]5WAZ:>(ZME6773OYU77UZ@ZZ3]<?[3&@Q[!\          $P#RQ<Z3
M.NB_:99:A:BX8@VX8Q<4557P_JZLE2E9Q]%(^ E.^7=F:9ETE;8K+.LU=BS:
M[':]%77D^ JY4IF<?12OA!7PKK&WU<#/PS;!R@
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M;M0O^)HVN5>"<\:SQM]+W-:G%0<].[1ZHOW7VR4N2005H
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M9?=<GH77[)NW-OP*@
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M-1&I/1RN5(V3OX<\"JBJY=8N9NK6"NCF1Z:.71WVS:>;) <P
M                     !XS/=Q,%VMQJNS#<3++9AN,VYJNJKQ=:AE/%KHJ
MI&SF7621VFC6,17N7@U%4\GFN=X;MQC]9E6>9-;L3QZ@:JU-UN4[((]=%5&,
MYEU>]VGNL8BN<O!J*H/Q51$U5=$(P7F&>814]3U:W;+;%*NS;(6*K;42U%0U
MT%9D=9"J^'4U$6NL=-&OO0PN]Y5TDD1'\C(HZG73US5'455MV\V[2JM.SUFJ
MFSRSSM6&JOU7"J\E1/'KK'3QKQBB=[RK]\D1'\K(Q1RR\_NM^;]LU9FMX'
M           ;L?)&R1:7>3>;$.9$;?,,IKPK->*K:KC%3HNG+W?6/I3V+W;>
M?)_OZTVZ^[.+<R(EYQ.GNJL[U6VUT<"+V=WQWI^1>X5-,OO.3TH22S?^"K
M                                                (D?FOXJN.=:F
M?W!K$CAS.TV&^0,1$1/WNAH)%31$^=)1O<OK52,%YF.-K8.KG-ZUK$CARRV6
M6\0L1-$_P&*B>J:(GSI*1RKZU4%#.FDB^M$4UOF @.$
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M]\]J*2NB3 "M
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M9*BRU\;>;THCG([3U Y8?UQOR_:)A!*C!7@
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MRPQX5SQQ*J\K7/N-4CG(G8BJC4U7U("DJ?G-]AI=-28*8
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MUFK,AQRM9:8T376O@9\11<._^^(F ^7MYFN3TIP(/I#Q!UH
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M/%_-7IV_A7(_Q%O-+_G%_FUL1_"=_P#Q-""FJ>QOM(\)HG!2
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M6\TO^<7^;6Q'\)W_ /$T(*:I[&^TCPFB<%(
M 9?] ?\ KD]/?\:H?Q,IE-T2?ZU^QG\98OQ4@.2+]<9[29Z2T@=@
M                                            1\_.RV;=%<-IM^[;
M2?>JR*;"<LJ6-T1)8EDKK6YRIVJ]KJIJJO<QB:]FFC?S>MJ'15VV.]=OI?O5
M5%+B&35#6Z(DD:OK;<YRIVJYKJEJJO<UJ>C04M2WYKOD4T'FD\%*
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MN(IK[K;3;_[WI'-3CR^,UGC.37YSW Z^1W.]5[NQ#%TQR!Q@
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M\1;S2_YQ?YM;$?PG?_Q-""FJ>QOM(\)HG!2
M &<7EM4;J[K<V$A93I4JRYW.H6-41VB4]GKIE?HOT$9S:]VAF+T 4KJSK V4
MA; E0K+C<)UC5$71(+562J_1?H(SF^0'+#^N-_\ QW$QHE9@KP
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M[J7>TMDJ(-->#?$IW3M7Z3N1./ %13NT<K>YW9[4)/I(K!6
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M5S51$;SVJII=7(O:GW_3AWZ YH$^^)ZD4EPDH(%<
M                                  1)/-&Z?%V0ZF;UD%GH/A<(WD9+
ME=@=&Q6PQ5\DG+=J1J]G,RH=XW*U-&LFC:G81@_,<V-79_J%N]\M5%\/A^Z[
M9,ELCF-5L4=;(_2Z4S5[-63KXNB<&LE8B H9V<K]4['<36\8!@X0
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MT$B-75DEWKTCGKGII_<V)#"J+V.8_P!(**=VK^7N;]LU.FLL'
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M\U>G;^%<C_$6\TO^<7^;6Q'\)W_\30@IJGL;[2/":)P4@
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MH..5G.Q43M3BA#Q5%:JM<BM<U='-7@J*A%65%:JM<BHJ+HJ+VHH.O/P_
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MM_"N1_B+>:7_ #B_S:V(_A.__B:$%-4]C?:1X31."D
M        -[_D>8QX^4=069OB1$M=KL-EIIU1-5^/GK*B5K5Y57A\&Q7:.3M;
MP7AINA\G;'?&R/?'+'Q:);K;9;13S*G;\;-53RM:O+W?"L5?>3M3@O<*JF3Y
MZ^Q"0Z;UP50
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M6S6K'+/:L?L5!#:[+8Z."@M%LIV\L5/34T:10Q1M[FL8U$0'8]G [8[,
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M% [1?>I;=1TT;%U_"RRI\GV!6TZ>XJ^E3<0;50<X
M                                   !8GJ3V$Q7J5V>RO:?*T2".\PI
M/8+TUO-+;+K3HKJ.MC3@J^&]='M14YXU>S5$<I9CJ V4QKJ"VKR;;+)D2&.[
M1>-9+LC>:2WW*!%=2U<:<%7D>NCFHJ<S%<S71R@^7M1[5:O?WD+'<K;K+-I,
M]RK;;.;:MIRO#KA+;KQ1ZJYG/'HK9(GZ)SQ2L5LD;T31S'-<G!2(_N#@>3;8
M9KDNW^8T"VS)<4KI*"ZTFNK>=G%LD;M$YXY&*CV.3@YCD<G!0=<Y%:JM7M0\
M.>.!^                    &Z7RWO,:IMHX;5L)OM=%9MDZ18L%SJ?F>M@
MDE>KO@ZQ41RK1O>Y58_^T*NCOO*ZQ;;N@3KU@VNBMNRF\]R5FWBO6/#,SFYG
MK9'RN5WPM6J:JM(YSEY7_P!I5>/WKC$*F&;E]QW9W*22[?<+?=Z"BNMJKJ>Y
MVRXP1U-ON-)*R:">"5J/CEBEC56O8YJHJ.:NBIV$@"AKJ*Z45)<K;607&W5\
M+*BAKZ:1LT,T,C4<R2.1BJUS7-5%14714!5E850    !K0ZZ?,/P;IGLEWP7
M!+A29=OO7TSX:&T4[F5%+C[Y$T;5754541[47GCI^+GZ(KT9&Y'.U\=9?79A
MO3W9[IAN&5U-E&]%;3OBH[7 YD]-8WO31M3<E151'M1>9D'SG<.=&L<CE'#)
M*C$T3B[T>@BD7Z^WG*+W=\DR*YU%YO\ ?ZR:X7J[U;UDGJ:JI>LDTTCUXN<]
MSE55(T-ZO5VR.\73(+]<)[M>[W535UVNE2]9)JBIG>LDLLCEXJYSG*JJ"B55
M5=5XJO:=2=8#\                  *JAH:RYUM';;=2RUUPN$\=-0T4#%D
MEFFE<C(XXV-15<YSE1$1.*J5-'1U=PJZ6WT%-+65U=,RGHJ.%JOEEEE<C&1L
M8W57.<Y41$3M4 F >7WTD4G2MLQ2T]\I(7;L9\V"Z[CW!NCG0/Y56EM;'IJB
MLHVO5'*BJCI72.1>56HDISH=Z8*7ILVFIH+Q2Q.W,S9L-SSVN;HYT+N55I[:
MQZ:ZLI6O5%T54=(Z1R+RJW0=A%'R-_3+\XSR,TP<@             !&3\Z/
M;5<=W^P/<JFIEBH-R<52DK)^7A)<K%,L4SN;U4M12MT]7V(\?FV[?K8=[L+W
M!IZ=8Z+<#&TIJJ;3A)<+-*L4J\W[GGITT]0*.H31R.]*?:--YJC!3@
M                   $K[RAO]3:R?QJOWXYA)C\K?\ U4+1_&6]?C6 KH/U
MM/:IL^-BH.8        T0^>+^:O3M_"N1_B+>:7_ #B_S:V(_A.__B:$%-4]
MC?:1X31."D                          )FOE^X(_;OHYV'L<T/@U=RQY
M,BJT5-'J^_SRW5O/KHO,UE4UNB]FFG<2R^A["W8)TI[+6>6'P:FOL27VJ14T
M<KKW-)<F\^O'5K*AK>/9IIW [")-(VIZM?LF8YE:#D
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M^KZU?@:IB)Z.>6&1R]R,5>P'#.W5FOT5U(K)&Q!0@
M      $K[RAO]3:R?QJOWXYA)C\K?_50M'\9;U^-8"N@_6T]JFSXV*@Y@
M    #1#YXOYJ].W\*Y'^(MYI?\XO\VMB/X3O_P")H04U3V-]I'A-$X*0
M                    ]GMSA=PW'W P?;^THY;EF]^MUBH5:G,K9+A4QT[7
M:>AO/JOJ/68%B5=GV<8?@]L1RW#,+U06:C5J<RMDKJAD#7:>AO/JH/UJ<RHG
MI70G<6BU4-BM-KLELA2FMMFI(*&WTZ=D<%/&V*-OR-:B$SVUVVCLULMUGMT2
M06^U4L-'0P)V,A@8D<;?D:U$!V9V)7@
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M 5P
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MB;00<X
M         !2UU#17.BK+;<J."X6ZX024U?05,;989X96JR2*6-Z*U[7M54<U
M4T5."E-64=)<:2JM]PI8:Z@KH7T];15#&RPS0RM5DD<D;T5KFN:JHJ*FBH 1
MP^OKROKG@,E\WEZ<+1-=\#59:[+-LZ9KI:RR-1.:2HMS?>?/2I[SG1_/A3YO
M-'KX>@WK:\NBX83)>-V-@[7+=,+59*S)MO:='2U5H:B<SYZ!OO.FIDXJYGSX
MD[.:/7PQ22PZ>\Q.'>TTDFH(%,
M        ;3^A+RW,MZC*NU[E;I4]9AVQ\,C)Z7F1T-PR5&.15BHD71T=,Y$5
M'U/?\V+F7F?'LDZ,.@+)]^JJV[@;D056*;.Q2-FIM4=#79 C7(JQ4B+HL=.Y
M$5'S]_S8M5U<P<\4*O\ >=P;]LE%XEB6,X'C5FP[#;'1XUB^/4S:.RV.@B2&
MGIX6=C6-;Z55555XN55<JJJJI(WQC&,>PO'[3BN)V:EQ_'+%3MI;19Z*-(H(
M(F]C6M3TJJJJKQ55555555!6(B(FB)HB=QZ([T'Z
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M3:(%XJVGHXFPQ\R\-7*C=7+WKQ!V2(B(B)V)V'JCT@/T
M                                                    T_\ 6SY6
M>);T273<O8A*# =T)N>IO&+N:D%DOLJZN<].1-*.I>J\7M18WK\]K7*Z4U8]
M7OEO8QNU)<=P=ETHL)W&EYZBZXXYJ0VB\R+JYSDY4TI:AZ]KT16/7Y[6JJR
MX)(4=[S>#O1W*1M,]V^S;:W*KMA&X>,5^(Y79)5BN5EN,2Q2L^B]J\6R1O3B
MR1BJQ[='-<K5130!FV#9?MQDMSP_.L=K<7R6T2>'7VBOC6.1OT7M7BU['IQ8
M]BJUR>\U51=04:HK5T5-%/''E ?@
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M>GB9!! QL<$$;4:QC&IHUK6IHB(B)HB("I.4Y
M    "(KYF/34_I]ZBKQ=;';EI-N=VW3Y+B#XV\L%/4R/1;G;VZ:(G@3OYVM1
M-&Q2Q)W*1=O,*Z?7[';\76Y6>@6FP+<]TV0XLYC=(8*B1Z+<:)NFB)X,S^=K
M431L<D:=R@H9F<K]4['<4-=I@@#A                      )!_DC;ITCK
M1O/LI5U+8JZGK:3-;#2*J\TT<\;+=<7HG8GA+#2(OIY_4;R_)_W(I76O=K:*
MJJ&QUD%739=9:55XRQS1LH*]R)V)X:Q4J>OG]0*NF=P<WY3?:;K05(
M !%[\Y;<RERSJ1QK +?4MJ(-K<6@@N;&NYO"N5WD6LE8J)V+\-\,ORD<[S8=
MPJ;)M_L?PBAJ&SP[;XY##<6-=KX=PNCUJY6*B=B_#_#J"CJ%U>B?10U#FK@%
M.                      ;XO)CZ<Y*Z]Y=U,Y%1:4=D9-BVW/BL3WZR=C5
MN=;&JIJGA0N;3M<G!?$F;VM-TGE,;"OK+QE'4+?J/2DL[9<;P+Q&I[U5,UJW
M&K8JIJGAQ.; UR<%\25O:T%53L[7K[$)#1O4!5
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MJHGWJ%&M71%=S.]X%6R-K.Q./>O>96F2X/L
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M\6H>KU:Q%5>5C->5C>QK41$X(#KG*KE55[5/''E ?@
M !<;:/:[*MZ=R<.VNPNC6LR/,[C'042:*K(6+J^>IET[(H(FOED7N:U5/>[7
M[<Y)NYN!BFW&(TJU=^RROCHJ1-%5D3%U=-42Z=D<,372/7N:U0?36JYR-3M4
MFU[.[5XQLEMAA.U6'P)#8<*MD5OII5:C7U,J:OJ*N5$X>)43.?*_3[IRDOK:
MG;;'=H-NL0VUQ6%(K+B-NBHH)%:C7SRIJZ>ID1.'B3RN?*_3[IR@[%K4:B-3
ML0N67!!^@
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M5LB18J"W0.5%6&CIM5;&U=$U7BYVFKW.7B"E<]SUU<OL0LB6?!\@
M             $F?RE^D"7:_")>H;/[2M/G>Y-"V+!Z&I;]\MN.R\LJ5'*J>
MY+7JC7^E(49HJ>(]I(7\L;I9DVZP^7?7-[8L&9[@4;8\.HZAOWR@L,O+(D_*
MJ>[)6JB.]*1(SLYWH"L@CY4YU[7=GL-RIMA!4
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M9Y)<'O;U61U.[Y\EMJGKQ\6%/FN7]<9HY%YD>C102QJQ>'S5[%,"#"@'$
M                                                 ;0?+6Z)*CJ0
MSYFX^?6R1NRFWM;&^OCF8J1W^Z1Z21VV-RZ(Z)GNOJ53[E6Q\%DYF[%_+\Z0
M9]_<V9GV;6Z1-HL&K&/K62L5&7NXQZ2,M[%7@L;/=?4*GW*HS@K^9HYX8^=>
M9?FI^B2N(XXX8V11,;%%$U&11,1&M:UJ:(B(G!$1"2]'&R)C(HF-CCC:C8XV
MHB-:U$T1$1."(B K3[/L
M
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MKJBZ.35CFN44$D:QKHO8O8IB>8S XP
M                 #,?HQZ.\TZN=QF6.@6HL.W>//CGW!SI(N9E) JZMI:9
M7)R/JI]%2-J_-361R*UNBY7=)G2KEO5#GC+/1+/9<$L;F39SF:1\S*6%>+:>
M!7>Z^IFT5&-7YJ:O<G*W11R1QK(OH1.U28%M[M]B&U>%X[M[@5EAQ_$L5I&T
M5FM4&JHR-NJN<][E5SWO<JO>]RJYSE5SE554E/8+@^+;;8E8<&PJT16/&,;I
M6TEIML.JHQC=55SG.57/>]RJY[G*KG.57*JJH*]$1$1$31$[$/9GK ?H
M
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MJ(B"N:U&HB(FB(7.+A@_0
M
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M)*6JI9'0U--,U621R,56O8]CD16N:J:*B]@*8X#A
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MYRZJYRJYRJJJH*M$1$T1-$3N/3'H0?H
M
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MB\6IQ2J5:.[P(UJ*_FHI^61S6:Z*^-'1^AZ@J&O:_P":NOJ,CR_H/L
M    PCZH^@78;JE@JKMD%H=AVY"P\E%N586,BK%<U/O:5T"Z15C$71%\1$DY
M4Y62L,0.H[HFV6ZCX:FYWRUNQ3/UBY*/<"RM;'5JYJ>XE9"ND=6Q%T1>=.?E
M]UDC <;XFO[4T7TH1U>I3RYNHOIRFK;K+CS]R=O(%5\6>XQ#)41Q1>FOHDYI
MZ1433F<Y'1:KHDKE-#G4#T%[\["RUESDL3]P,%A571YKCL4D[(H_36TB<TU,
MJ<-7.18]5T21R@I'PO9W<R>E# DPI!Q
M   &573QT8=0/4S60.VZPJ>'%G2^'6[@WCFH;) B+ROTJ7M59W,7M93MD>G>
MU$XF2FQ727OCU"U<+L#Q&:+&UE\.LSBZ\U':(41='Z5#VJLSF][(&O>G>U$X
M@Y&1O?V)P]*DB_I/\L[9/IPDMV6Y%&S=?=:EY)H<INU.U*&VSM1%UME JO8Q
MS7)JDTBOE335BQZJTWS],OE[;0[!/H,GOS&[F;ETW)+%D=S@:E';YD1%UMU$
MJO:QS7=DLBND335JLU5 5;(6LX_.=Z39&9^@Y0
M
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M&-.YD;6M3T I'.<Y=7+JI;D\$#Y
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MB?=:&:GAE7C^LSN;X4J<%XL<J X5:YOSFJA;(MX#Y
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MXHHV)HUC&-1$:U$31$1 <Q4E0
M
M              >?RK*\:P;';OEN8WVBQK&;#3NJKS?;C,RGIJ>%NB<TDCU1
M$U541$[5541-55#H\ER7'\.L-TRC*KS1X]CUD@=4W:\U\K8*>")NB<SWO5$3
M551$3M551$XJ#\541-571$[R,/UT^9EEF_TMXVPV<J*W#-EG*ZFN5Q3FI[KD
MC.Q_Q*HJ.@I7=B0(NKV\95][PF1V>LOS"LFWMDNNW6U,]7B>TCE6GKZ].:"Y
M7]G8_P =47FAIG=B0HNKTXRKQ\-HHY9E=[K>#?3Z34V:R0<
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MNB<U#9:"GH8G::Z*YL#&(Y>*\5X@Y$1$[$1/8>S/6 _0
M
M                                   #H<HRC'L*QV]9=EEXIK!C6.4<
MM?>[S6/2."FIH&J^21[E[D1.Q.*]B<3I<CR.Q8C8;OE&376GLF/V&EEK;Q=J
MIZ,AIZ>%JN>][O4B=B<5[$X@*J(FJ\$3M(FG7GUYY/U7Y._&<9?5XWL=C=6K
M\<QQZ^'/=)X]6MN5R:U=%>J:^%%JK8FKWO5SEC(]:?6GD74QD3L>QYU38-G;
M!4JZPV%R\DURF9JU+A<$:NBO5-?#CU5(T7O<KG**"657KHG!J=B&NPP/!Q
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MT1S5[4!6HY'(BHNJ*7$/=@_0
M
M                                                 #\54:BN<J-:
MU-55>"(B'XJHU%551$1-55>Q$ (MGF:==-1OSEM7LOME=U39C"JYS+K<J5WN
M9)=:9^BSJ]%5'TE.]JI B>Z]VLR\WWKDC@^89UES;U9/5;2;>714VFQ&L5MS
MKZ9WNY!<J=VBS*]%T?30.14A1.#UUE7F^]\@HII>9>5OS4[?6:ES6,#@
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MJ^'+$[@Y-51>#FJYCFN45S7(Y$<G8I=4N4#Z
M
M
M-./FP]8LFU&$Q]/NWUT6GW!W(H'2YE<J9^DEJQ^7FC6%'-5%;-7*CF)WMB1Z
MZ)SQN-4GF9]5DFVF(,V-P>XK!G.?T3I,KN%._22VV.7FC6)%:NK9:Q45J=[8
MD>NB<[' IYY.5.5.UW;ZD(R)'B!1@
M                            &:?1'UB95TD;FPW5KJB\;8Y/)%2[BX>U
MZZ2P(NC*ZE:J\K:FGU56*OSV\T:JB.1S<N.D#JJR3I@W#BN373W7;O(I(Z?/
M,5:]=)8471M93M5>5*B#55:OW3>:-53FYFCDBD6-WZ5>U"8+A^7XUGV+6#-<
M.O%/?\7R>BBN%CO%*[FBGIYF\S7)V*B]SFJB*U=6N1%14)4.*Y3C^;8Y9,NQ
M6ZP7O',BHXJZSW6F=S1S03-YFN3O1>Y6JB*U=45$5%0%>BHJ(J<47L/2'?@_
M0
M
M                    "W&[VY^-;+;99MNIE\RQ8_A%JFN59&U4;).]B(V"
MFB5W#Q*B9S(HT7@KW(>"W2W%Q_:3;S+]R<IE6.QX?;9;A5L:J(^9[4Y8:>-7
M</$GE<V)FOW3D!^.5&HKE[$(2&[FZ.5;T[DYCNCFE8M9D>9W&2OK5U560L71
MD%-%KV101-9%&G<UJ(1 =T-QLDW<W RO<?+JI:N_997R5M6NJJR)BZ-AIXM>
MR.&)K8V)W-:@.N<Y7.5R]JEN3P0/D
M                               W.>4]UF3;;9E3=-^X=W1NWN>UJKM_
M<*I_N6B_5#DTI6N=\V"O=P1O8V?E5$3Q9'&V;RS.K&7 ,LI]@LZNB-P;-:M5
MPBNJ7^[:[U.J:4R.7YL-:[AIV)-RJB)XDC@5$$FB\B]B_-]I)@)"0*P
M
M
M               T >='U!O1V"=-F/UZM8K69=N)'$[YW%\-JI)%;Z-)9W,7
M_B7^@TA>;;OD]'89T_V.M5&*UN49VR)W;Q=%;:9ZIZ-))G,7_BG>@%+4/[&)
M[5- 1I$!2@
M             'W'))#)'+%(Z*6)R/BE8JM<US5U145.**BGW'(^)[)8GNCD
MC<CHY&JJ.:Y%U145.**B@$P3R[NJ7^D[L+;JN_UZ5.YVWBPV'<-KEUEJ)$8O
MP=R<FB<*R)BJY?[JV5$X(A*@Z$NH_P#I$[*T%3>ZU*C<3!%BLN=M<NLD[T8O
MPMP=P3_"HV*JK_=&R(G!$!7Q/YV\>U."F>IFJ#E
M
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M:WO[0>B/>F2
M        /Q'-551'(JM^<B+V>T^&R1N<YK7M<YGSVHJ*J:^E.XX8ZFGFDFAB
MJ(Y9:=42HB8]'.8JZZ<R(NJ:Z+V@_3[.8'F:_)Z6BJ7TS(7U#HEY97(J-1%[
MT37770MU?-Q[;9[A+;XJ.6ODIG<E5(UR,:UR=K4U1554[S%S<+JGQ3!\EK,8
MI+)5Y'56J7P+M512L@ABE;P?&Q7->KW,7@[@B:\-0=W0UL%PIV5-.J\C]45K
MN"M5.U%/8V:\4=]H(;C0N<L,NJ.8]-'L<WM:Y./%"^>"9Q8MQ,;HLHQ^21U#
M5JZ.2"=J,F@FC71\4K4541S?4JHJ:*BZ*"K.T/8
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MUD;=5T35=0=L>I+P
M  $>WSO=QWR7K8_:.FJ>5E%17'+[U1H[YZU4B4%OD5O=R_#U2(OZ931EYP>?
M.DNVSNU]/4<K*2DK\IN]*B_.6HD2BH7JW]+X%2B+ZU!2U*_-;\JFA4TJ I0
M          #(OI)VBIM]NH_:/:VX1NFL^27UDF10M545]KM\<E?7L1R*BM5]
M/3R-1=>"J7YZ8=KJ?>;?W:_;BNC=+:K_ 'EC[[$U517VZAC?6UK$<BHK5=!
M]J+W*H/N-O,]K>Y5XDVNGIZ>DIX*2D@CI:6EC;%34T349''&Q$:UC&M1$:C4
M31$3L)?4$$%+!#34T+*>FIV-BIZ>)J,9&QB<K6M:W1$1$31$0'8G,<H
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MCM4<US55%1>U"GJZ2EKZ6IH:VGCJZ.LB?!5TLS4?'+%(U6O8]JZHK7(JHJ*
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MXSV^MG_YLJ_WO^/^:SM_Q?YWZYZNSU@Y2J.X
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M>QR*A,6M=SH+W;+=>;55,KK7=Z6&MMM;'KR34]0Q)(I&ZZ+HYKD5 =D=B5X
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M8U$0F*VFUV^QVNVV2T4C*"U6>EAH;90Q<&0T].Q(XHVZZ\&L:B(#LCLCL
M    #H,JR:S85C&1YCD=8VWX_BELJ[Q?*Y^G+#24,+IYY%UT^:QBJ=)DN0VG
M$<=OV5WZJ;0V/&K=576\5CNR*EHXG33/773YK&*H/Q5T157L3M(..].Z-YWJ
MW8W W6OZ.9<LYO53<UI7/63X:"1W+34K7JB:MIX6LB;^E:A#GW<W&NV[NYF;
M[EWOF9<,RN]1<5IG/Y_AX7NTIZ9KETU;!"UD;?4U =<YW,Y7+WJ6P+= ^0
M             "9[T!_ZFW3W_%2'\=*2TNB3_50V,_BU%^-D!V,7ZVSV&7YE
M,#[                                              !YS*?WI?^%9
M]L\!N7^:\W[HA^VIC3U8_P T%9_"E#^K<#QV-_OU1?\ *?BW%I=OOSOM'_./
M\GD,+>F7^>_"?^\O_+:H%U#)DVT
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MUTY:A%F:G'O1'HB@[&/];9[#+(R;!]@
M                 XY889V\D\3)F:Z\CVHY-4]2E/4TE+6Q>#64T57#JCO!
MF8CVZIV+RN14X'67:RV>_P!)\!?+51WFAYVRK15T#*B%7LUY7+'(CFJJ:\.
M$<,42:11,C3T,:B?:/V"EIJ5O+34\5.WZ,3&L3["(A]6^SVBT1^%:K71VR+^
MYTD$<+>[NC:U.X'(<YV(
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M@RIBF,*QW-&Z*W/>E5,S3@J2U3I7-<G:SDXKH@*"9W,]?0W@A@<86@X@
M             "<7TQ6?\G^F[I_LBQI'):]N<7IJA$C\+65EIIDD<K.Y7/U5
M=>.J\>),5Z=[5]1[ [(6=6)');<"QRGG1&>'K*RV4Z2.5G<KG:JNO'7M!V3$
MT8U/0B%\2\8/H
M
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M(
M
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MYI9?C6^FFAK(YJC3M_M3' ^XTU>Q/6A-\)A(.Q
M
M                                                    (2W6+BCL
M*ZJ>H+'U8L<4.=WJLHXU14Y::X53ZVG;Q5572*=J:]_:1!^JS&G8CU)[XV-6
MJR.+,[O5TD:HJ<M/75+ZR!.*JJZ1S-37O[0==(FCWIZS&PQ_!\
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M>)3[=8_>\CJ&JW5OOTWU5'KKV*V2X-<GK0V%>6%A[LHZL,<NJLYX,#L=WO\
M.U4U;[T'U;'K[)*YKD]: YH$UDU]":DLLDW K@
M
M                                                   ")[YN>$KB
MG6/?[VV%(H-Q<:LF01.;\USHH'6F1>S1%5UO553UZKVD9CS0\07&NJV]WAL*
M10YYC]HOD:M^:YT4*VQZ]FB+S4.J^W7O!0SII)KZ4136*:[@<(
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MJF3YSOD0W]&[@%4
M
M                             :!_._P%74^P^Z--!PBDN^+7FJT7CXB0
MUM S7LX<E4II(\X7"56#9?<:"'A')=,;NM1HO'G2*LHF:]GW-0H*6I3YKOD4
MC]FCX%*                    ;N/);WN7']RL]V&NM:K+;N!0?E#BE.]WN
MI=K4WEJHXV_2GHUYW+Z*=#;_ .4EO MDW S79:YU:MM^<47U[C4#W>ZESMK=
M*F.-OTIJ5>=R^B! 5-.[159Z>*$D0W\@JP       #6#YL^RG\J/2W<,QMM'
M\1DFR]PCR6E?&SFF=:Y=*6Z1(NBZ,;&]E2_U0(:ZO,XVB_E&Z<*[*Z"E\?(-
MI:YF04SF,YI76Z32GN4:+HNC$C>VH?ZH0<,[>9FO>WB7M\O[8[^03I9VXQFN
MI$I<IR:F_*S-$TT?]87AK9DBD35??IZ=(:=VBZ:QZIVEW^A_9W^13IOP''JR
ME2FR3(:?\ILM331_QUT:V5(I$U7WH($B@73AJS7O!]1-Y6-3O7BIFB9; Y
M      "&OY@>^Z]0'5%N#DE#6K68EBL_Y)X.K7<T:VZTO?&Z>->'NU-2Z:H;
MPUTD1%["*!UQ;T+O?U&YS?Z*K6JQC&IOR8PY4=S1K06Q[XW31K]&HG66=.&N
MCT3N!02NYGKZ$X(85F(P.(                    E[^5_MH[;;HWVV=4TW
MPUTW!DK<RN;=-.=+G+RT3_7S4,-.I*5\NG;YV =*.W[JB#X>Y9R^KRRXMTTY
MDN,G+2/]?-1PP*"OA;RQM]?$V"F<8.4
M
M                                             UY>:1ML_<7HVW$F
MI:=:FY[>5-OS"VQHFNB4$W@UCUT[.2BJ*AWR?*8*^8[@#L\Z4,[EIX%J+C@M
M10Y50,1-=$HI?"JWKIV<E'/.[Y/E!Q3)K&[U<2(@1<04
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M3T'>'<
M
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MZ\W1C).1W<[P*5(^5>Y9)&]NH*.H=JY&I]SV^TTT&IT%.
M     ;4?*'VA?N#U2,SJLIUDL>S=FJ;U)*K=8W7*O:Z@H8G+W+I+-,WUQ&R7
MRN-K79SU',S.K@5]GVHM-1=GR*W6-;A6M=144;O0NDDLK?7$#GIVZOU[FH2J
MR2F"M
M
M                       (GWFT;0.VVZK;ME=%3+%8=X+739+2O1/O;:^-
M/@KA$B]O,LD+9W?AD]B1F?,YVL=M_P!2]SR:DIUCLNZENI\@IGI^MMK8T^$K
MHT7MYEDA29WX5/8@H9VZ/U[G<36(:[0<(                   !LO\J7>W
M^2?JHL>,7*K\#&=Y:1V)U['NTC;<7N2:U2Z=[UJ&?#M_#.-A'EI;O_R9]2=G
MQVOJO!Q[=BF=C%:QZZ,2O>Y);9)IWO6=O@-_"J#F@=ROT[G<"6:2< 5P
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M@W[=JO??I7.;I(VVPHM/;HU7O:K6OG;ZI05T#>5FO>[B;1#8T#F
M
M
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M]QJWZSR.)BKS-M%K>UT;'HFG":JY%;^"<@*>H=HU&][NWV$:<CZ@HP
M             "[VP>TEWWVWDVZVELR2-J<UO,%%6542(KJ6A:JRUU5[VJ?W
MO3,DET[^73B72V3VPNF\VZ^![8VE)&U&77:&DJJF/174U&U5EK*GCJGWBG8^
M3_>@^F-5SD:G>3B+#8[5C%CLN-6&BCMMCQZ@IK99K="FD=/24D388(F)W-8Q
MB-3V$Q.RV:V8[9K3C]EI([?9[%106^TT$2:,@IJ6-L4,34]#&-1$!V2<."=B
M';'9@
M
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M5(M7CE2W)\5A>OO.HJQ6P5T;$TX-AG2-_K69?0"KIW:HK?1Q0WIFY8%2
M          0O^NK?9.H;J:W%SBAJTJ\6ME5^3F"O:Y71K:+4YT,,T>O'EJ9/
M$J=.Y95(E?69O/\ RZ]0V>9C1U*5.-V^I^H,-<U>9BVNV.=%%+'K]S4/YZC3
MN610=?*[G>J]R<$,0S%L'&                    ;_ +R7.GQR+G74I?Z!
M41R/Q';U\K."\6372KCU]&D<#7HG]V;KVH;O/*3V-<GY9=0-[HE1%1^+X*^5
MO!>+);E51Z^R.%KD_P"-;KV@JJ=G:]?8AO\ C=X"J
M
M
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M&IV(7-+A@_0
M
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MM\K48ZJ35.WX>-L<7'YK_$0%'4/U<C4[&]OM-1)JZ!3@
M   $@'R;>EYS&WSJFRZW*U7I4X]M.R9JHO+QBNESCU3L7C2QN1?\814^:IN_
M\J'IS<Q+QU(910*U7I46+;)DK51=.,=RN#-4[%XTS'(O]W14[%!54[.UZ^QI
MO[-W(*H
M
M                                 C%>;UTROVWW;H=^<9H/#P[>"1T>
M2-A9I'1Y)3QHLJNTX)\=$WQD[W2,F5>XCM^:5T\NP'<^CWJQZBY,5W4D5F0)
M$S1E+?X&(LBNTX)\9$GBIWJ]LRKW HZAFCN=.QW;[33P:JP4X
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MO%0=@B(B(B=B=AZ@]&#]
M
M                                              +)]1.Q^,]1>SV9
M[2Y2B0TN2TG_ &5=4;S26^Y0+XM%61]BZQ2M:KD14YF<S%X.4M#OOL[CV_.U
M>6[89&B14V04O_9MR1O,^AKX5\2DJV=BZQRM151%3F;S,7@Y0?+FH]JM7O(4
MFXVWV4[4YUE6W.;6YUJRG#KC-;;Q1KKR^)$ONR1N<C>>.5JI)&_31S'-<G!2
M(GGN#9)MIF>28%E] ZVY)BE=+;[K2KKR\\:\'QN5$YHY&JCV.TT<U4<G!0=<
MJ*U51>U#Q1Y$'X                    ;!.C3S"=T.D^=F,5,#MP=H*R=9
M:W!:R=T<M ^1VLD]IJ%1_@.5=7.C5JQO77@U[O$3./I/ZY]QNF:9N.U$+LYV
MMJIEDJ\-JIW,DHG2.UDFMDZH[P7*OO.C5%C>NO!KEYP<L<KF<.UOH)%>S/7_
M -*>]U)1KC^ZELQ>_P!4C4DP_+9&66XQRN37PF)4O2"H=I_B\LB>LWQ[3=;W
M33O!2TBV/<FWXY>ZA&I)BN3R,M%>R1R:^$U*AR0SN_ 22)ZP5;96.[':+Z%X
M&8E)64=PIHJR@JH:VDG15AJJ=[98WHBJB\KVJJ+HJ*G!3*JEJZ6N@CJJ*IBK
M*69%6*I@>V2-R(JHO*YJJB\4T!R'E\NW#P#;^D=7YWG%@PNA8SQ'5E]N5+;H
MT9JJ<W-4R1IIJBH>=RC.\(PBE=6YIF-DQ&C8SQ'55YN%-01HS54YN:HD8FFJ
M*#\543M5$]IJQZE_-XV:VYH*ZP[#1-WASES7Q0WM[)J;'*&314YY)G)'-6*U
M=%1D"(QR?V]JIHNMOJ#\T?:? J*MLNRT3=U,R5KHXKNYDL%@HY-%3GDE<D<M
M4J+HJ-A1&.3^W-7@#A?.UO!OO+^@1QMT]U]P-ZLUNVX6YF35>595>'ZSUU2[
MW(HD<KF4]-$W1D,,?,O)'&B-;W)VFA#<G<S.-W,NN><[AY#4Y)DEU=K-65#O
M=BC155D$$3=&11,YEY8V(C4[D!1N<KEU<NJENSP@/P
MY8()ZJ>&FIH7U%34/;%3T\35>][WKRM:UK=5555=$1#DAAFJ)HJ>GB?//.]L
M<$$;5<][W+HUK6IJJJJKHB( 2XO+BZ/V=,&T*7C+*!C-X-RHX;AF;WM19+92
MM174EI8[N\)'<\VG;*Y4U<V-BDH/H'Z6&=.NUJ77)J)K-U-P60UV6O>U%DM]
M,B*ZEMC'=WA([GET[955/>:QB@KXH^1O'YR]IL5,\0<H
M
M
M             !IZ\U+HJEWBP]V_>VEH6IW.V_H7)EEGI6??KY8H$5[G,:B:
MR5-$FKF(GO/BYV)S.;$PU6>9-TC2;JXJ[>O;ZUK/N)@]&J9/:J9OWV\6:%%<
MKFM1-7U%(FKFHG%\?,Q.9S8V@X)X^9.9/G)V^M",01V@40
M         !645QN%LE=/;JZHM\[V+&^:FE?$]6*J*K5<Q4735$70JJ.OKK?*
MZ:@K)Z&9S58Z6GD=$Y6JJ*K55BHNFJ)P UT["C*4
M     WJ>5#T/NR*XVSJEW3M/_8-FJ%DV>Q^KCU2LKH'<JWF1CN'AT[T5M.BI
MJZ5%EX)&Q7[F/+.Z/'7VOMW4AN3;/^Q;3.K]J['4LU^+K(7:+=I&N_M<#T5(
M-4XR)XG!&,5XJH(_NW?[U/ZI(H-\ *H
M
M
M     C:^9SY?L^W]TO/45LK8G2;?W>:2MW*Q&@CX6&JD5'/N%-&W5?@YG*KI
M&M32!W%/O3M(M 'F(]#\^#W&[;\;1V5TF#W262KW!Q>BCX66ID5'/KJ>-O'X
M65RJKVHFD+N*?>G:1BDFBT]]J</ND-)IJ&!3
M                        &RKR\^A.Z]468LS7.*.IMNQ>'U;?KNKT?$^^
MU<?O);*.1-/=3@M1(U=6-5&MT>]'-V!]"W1E<^HW*F9=F-+46_9K%:IOUQ5:
M/B?>JIGO);J61-/=3@L[VKJUJ\J:/<BM'-%%SKJOS4_1)8MMMMOL]NH+1::&
M"V6JU4T5';+;2QMA@IZ>!B1Q0Q1L1&L8QK4:UJ)HB)HA)JM]!0VJ@HK7;*.&
MW6VVP1TMOM]-&V*&""%J,CBCC8B-:UC41&HB:(G %<5I5@
M
M
M                    '#44]/5T\])5P1U5+51NBJ::5J/CDC>BM<Q[7(J.
M1R+HJ+VG%/!!5034U3"RHIJACHJBGE:CV2,>G*YKFNU145%T5% (U/F'>6O<
M=KJR][V[ V.6X[7SJ^MS#!J-JR3XZ]SD5\])$FKI*)5756HBK!Q_M7%D?;KK
M\OVOVYJKON_LC9Y*_;F97UF58;2M5\]B>YR*^:EC35SZ1==5:FJP\?[5Q8*2
M6'35S$X=Z>@TOFI4%,
M  ;!^AGH+S3JRR*+(;Q\1BNR5@K6Q9/EG+RSU[V>\^@M:/:K7RJFB/D5%9$C
MM5YG<K'9R]&_15EO4W?H[[=?'QO:"R5C8\BR;3EGK7L]Y]%;4<U6OD5-$?(O
MNQ(NJ\SM&.'+%$KUU7@U.U26;A6%XOMUB>/X-A5EI\>Q3%J**WV*STJ*D<$$
M2:(FJJKG.<NKG/<JN<Y5<Y5<JJ2<,1Q+',#QBQX;B-I@L6-8W1QT-FM5.BI'
M##$FB)JJJYSE757.<JN<Y5<Y5<JJ"N1$1$1$T1.Q#U!Z,'Z
M
M
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MYJ^I4!2*BHNBIHJ=QTYU0/P
M VV]#'ECY;OK/:MS-[*2MPK9M.2JMEG=S4]VR-NJ*U(6KH^FI')Q=,NCWIHD
M*:.\5FS[HV\N_)]YIK9N%N]2UF(;4>Y4VZU.YH+G?V\%:D2+HZGIG)Q65='.
M31(DX^(P5$4*N]YW!O<GI)..+XOCN%8]9\3Q&RT>.8U8*9E'9K)01-@IJ:"-
M-&LCC8B(B=Z^E>*\21!CF.6'$;%:L9Q>T4MAQ^R4[*6TV>BB;#3T\+$]UC&-
M1$3TKZ5XKQ!6(B(FB<$3N.^.Z
M
M
M          ,2NI_HMV2ZK+.L6>61;3F5'!X5AW'LZ,ANU)RZJR.1ZM5M3"BK
MQBE14XKR*QR\R8P]1721M!U*VI8\TM"VS+*6'P[+GUK1D-SIM-58R1ZM5L\*
M*O&.5%3BO(K'+S ^'QM>G%./<I&LZH_+NW]Z9IJ^]SV=VXFV,#G.@W#Q^%\D
M<$7%46Y4:<\U&J(B<SG<T.JHC97+P(_74=T);V]/4M;=YK6[.]NX7*Z'.['$
M^1D,7'1;A2IS2TJHB)JYW-%JJ(DJKP!1OA<SCVM]*&!9A4#B
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M#:@B(U$1$1$1-$1.Q$!SGZ?H
M
M
M            !^*B.16N1'-<FBHO%%13\5$<BHJ(J*FBHO8J &N7J,\L+INW
MZDK;[9[2_:#/*KGD=DF+0QQT=1,Y%T?6VM>6"7WEYG+%X4CE^=(I@5OUY=>P
M.]3ZR\VJV.VLS2IYGNR#&XHV4L\KD71U7;5Y89.*\SEC\)[E^<]0<3X6/XZ<
MJ^E#1]OKY6G5-LXM9<K%CD6\6)P*YS+SAZ/J*UL::\OCVEZ)5(Y435?!;*Q.
M]YIXWF\M_J0VI6JN%EL$>ZN,PJYS+MBJ/GK&L373QK8]$J4=HFJ^$V5J?3!3
M.@>WL]Y/4:ZJ^@KK56U5MN=%/;KC0RNAK:"JC=#-#*Q=',DC>B.:Y%X*BIJ8
M'5M%66VKJ:"XTDU!7T<CH:NBJ8W1312,71S'QO1'-<B\%14!PE(4H
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MYSE3O!4HU&IHU-$+C'O0?H
M
M
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MP^\8ON#1HJI!#3UC[;7.1.]\5;&R!NO=I4.!Q+3O3L5%,.\QZ'.KK!%E^O\
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M<>6..-&M:GJ1 <I7E:
M
M
M                             =!EGYK9+_!59^(>=)DWYMY!_!M7^)>
MO8IH:ZJOUS+_ ,+;?Q=.:6>I/]<RG\);_P 7 "G?WF YA0#C.XQ[]_['_"%-
M^-:=K8OW[LW[NI_QK0?J=J&\_H]_PQO\(5W^1Q&Y'I5_PI/W=6?Y)&#G8;%3
M/('(
M
2                    ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139914110540400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 11, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">vTv Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3916571<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3980 Premier Drive, Suite 310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">High Point<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">27265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">841-0300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class&#160;A common stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VTVT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001641489<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>vtvt-20230811_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vtvt-20230811.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001641489</identifier>
        </entity>
        <period>
            <startDate>2023-08-11</startDate>
            <endDate>2023-08-11</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001641489</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName contextRef="c-1" id="f-23">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">vTv Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37524</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">47-3916571</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3980 Premier Drive, Suite 310</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">High Point</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">27265</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">336</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">841-0300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Class&#160;A common stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">VTVT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MKVFWTZ,(WG6)=WT.WCB.8;&;B_<;\@F^(U]D[2SBBNWKOD^FFJ<"G.A.0ZV
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M>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^ Q1'
ML#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,,
MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@
M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2G0P^
M\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$
M%     @ E80+5Y>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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MOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ E80+5P=!36*!    L0   !
M             ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "5
MA M7/WC_:^X    K @  $0              @ &O    9&]C4')O<',O8V]R
M92YX;6Q02P$"% ,4    " "5A M7F5R<(Q &  "<)P  $P
M@ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )6$"U? EK\(
M500  )40   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T
M,2YX;6Q02P$"% ,4    " "5A M7GZ ;\+$"  #B#   #0
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:+GAM;%!+!08     "0 ) #X"  #L$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="vtvt-20230811.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vtvtherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName -  vtvt-20230811.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="vtvt-20230811.htm">vtvt-20230811.htm</File>
    <File>vtvt-20230630xexx991pressr.htm</File>
    <File>vtvt-20230811.xsd</File>
    <File>vtvt-20230811_lab.xml</File>
    <File>vtvt-20230811_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vtvt-20230811.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "vtvt-20230811.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vtvt-20230811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vtvt-20230811_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vtvt-20230811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "vtvt",
   "nsuri": "http://vtvtherapeutics.com/20230811",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtvt-20230811.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://vtvtherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vtvt-20230811.htm",
      "contextRef": "c-1",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://vtvtherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001641489-23-000051-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641489-23-000051-xbrl.zip
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M45;W*N<ZVG88<>3+G@A&\"-4<?3Z_P%02P,$%     @ E80+5Q- CP0C#P
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M_EL6,@';2B<$%#,9F)&6;NEJ]8[=;:3OE1V[VUN?NN]TF+\]V9<(_K>4G=^
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MVKL_T'ZU+\4?[?T/4$L! A0#%     @ E80+5QUN?I0:&P  I%T! !X
M         ( !     '9T=G0M,C R,S V,S!X97AX.3DQ<')E<W-R+FAT;5!+
M 0(4 Q0    ( )6$"U<30(\$(P\   IE   1              "  58;  !V
M='9T+3(P,C,P.#$Q+FAT;5!+ 0(4 Q0    ( )6$"U<<$DJK< (  'D'   1
M              "  :@J  !V='9T+3(P,C,P.#$Q+GAS9%!+ 0(4 Q0    (
M )6$"U<]75;=10H  !I=   5              "  4<M  !V='9T+3(P,C,P
M.#$Q7VQA8BYX;6Q02P$"% ,4    " "5A M7&(LCA:X&  #D,   %0
M        @ &_-P  =G1V="TR,#(S,#@Q,5]P<F4N>&UL4$L%!@     %  4
*4 $  * ^      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
